FDA Approved: LETROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for letrozole, a generic aromatase inhibitor used to treat breast cancer in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)